Market Overview:
The global chlamydia trachomatis nucleic acid detection kit market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chlamydia infections, rising demand for nucleic acid detection kits for diagnosis and research applications, and technological advancements in nucleic acid detection kits. Based on type, the global chlamydia trachomatis nucleic acid detection kit market is segmented into DNA, RNA, and DNA/RNA. The DNA segment is expected to account for the largest share of the global chlamydia trachomatis nucleic acid detection kit market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing demand for molecular diagnostics for accurate diagnosis of chlamydial infections. Based on application, the global Chlamydia Trachomatis Nucleic Acid Detection Kit Market is divided into two segments: diagnosis and research applications.
Product Definition:
A Chlamydia Trachomatis Nucleic Acid Detection Kit is a medical device used to detect the presence of Chlamydia trachomatis DNA in a clinical specimen. The kit is important because it can help physicians diagnose and treat chlamydia infections.
DNA:
The DNA, it's usage and growth factor in Chlamydia trachomatis (Nucleic Acid Detection Kit) market is expected to witness significant growth over the forecast period. The major drivers for this market are growing prevalence of sexually transmitted diseases coupled with increasing awareness about these diseases.
RNA:
RNA is a nucleic acid that acts as a genetic molecule for the synthesis of protein. It is found in all living organisms and plays an important role in the regulation of cellular activities such as gene expression, protein synthesis, and signal transduction.
RNA (rna) consists of ribonucleotides & deoxynucleotide triphosphates (dNTPs). dNTPs are used by cells to make DNA which encodes for genes.
Application Insights:
Based on application, the global market is segmented into diagnosis and research. Diagnosis dominated the overall market in terms of revenue in 2017. This is attributed to high usage rates of C. trachomatis nucleic acid detection tests for diagnosis compared to other applications such as research or screening programs.
Screening programs are anticipated to witness significant growth over the forecast period due to rising awareness about STDs and increasing government initiatives for population screening and targeted prevention campaigns especially in developing regions such as Asia Pacific, Central & South America, Africa etc.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of players, high awareness levels coupled with relatively higher healthcare expenditure and better reimbursement policies within this region. The U.S., which accounts for over 85% share of North America market, is one of the most impacted countries globally due to rising cases especially among adolescents & young adults along with an increasing number of immigrants from other regions that are affected with Chlamydia trachomatis infection.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to improving economic conditions.
Growth Factors:
- Increasing incidence of chlamydia trachomatis infections: The increasing incidence of chlamydia trachomatis infections is the major growth driver for the Chlamydia Trachomatis Nucleic Acid Detection Kit market. According to the Centers for Disease Control and Prevention (CDC), there are approximately 2.86 million new cases of chlamydia in the U.S every year, out of which around 1 million cases go undiagnosed and untreated every year. This high prevalence rate is expected to drive demand for Chlamydia Trachomatis Nucleic Acid Detection Kits over the forecast period.
- Rising awareness about sexually transmitted diseases: There has been a rising awareness about sexually transmitted diseases in recent years, owing to which people are increasingly getting themselves tested for various STDs including chlamydia trachomatis infection. This is another major factor that is expected to drive demand for Chlamydia Trachomatis Nucleic Acid Detection Kits over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chlamydia Trachomatis Nucleic Acid Detection Kit Market Research Report
By Type
DNA, RNA, DNA/RNA
By Application
Diagnosis, Research
By Companies
Sansure, Mole, Amplly, SinoMD, Kingmed, Daan, KHB, Innovita, Geneodx
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Chlamydia Trachomatis Nucleic Acid Detection Kit Market Report Segments:
The global Chlamydia Trachomatis Nucleic Acid Detection Kit market is segmented on the basis of:
Types
DNA, RNA, DNA/RNA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnosis, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sansure
- Mole
- Amplly
- SinoMD
- Kingmed
- Daan
- KHB
- Innovita
- Geneodx
Highlights of The Chlamydia Trachomatis Nucleic Acid Detection Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA
- RNA
- DNA/RNA
- By Application:
- Diagnosis
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chlamydia Trachomatis Nucleic Acid Detection Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Chlamydia Trachomatis Nucleic Acid Detection Kit is a test that can be used to detect the presence of chlamydia nucleic acid in a sample. This kit is typically used to screen for the presence of chlamydia infection in patients.
Some of the major players in the chlamydia trachomatis nucleic acid detection kit market are Sansure, Mole, Amplly, SinoMD, Kingmed, Daan, KHB, Innovita, Geneodx.
The chlamydia trachomatis nucleic acid detection kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chlamydia Trachomatis Nucleic Acid Detection Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chlamydia Trachomatis Nucleic Acid Detection Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chlamydia Trachomatis Nucleic Acid Detection Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chlamydia Trachomatis Nucleic Acid Detection Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chlamydia Trachomatis Nucleic Acid Detection Kit Market Size & Forecast, 2020-2028
4.5.1 Chlamydia Trachomatis Nucleic Acid Detection Kit Market Size and Y-o-Y Growth
4.5.2 Chlamydia Trachomatis Nucleic Acid Detection Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA
5.2.2 RNA
5.2.3 DNA/RNA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnosis
6.2.2 Research
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chlamydia Trachomatis Nucleic Acid Detection Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chlamydia Trachomatis Nucleic Acid Detection Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA
9.6.2 RNA
9.6.3 DNA/RNA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnosis
9.10.2 Research
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA
10.6.2 RNA
10.6.3 DNA/RNA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnosis
10.10.2 Research
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA
11.6.2 RNA
11.6.3 DNA/RNA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnosis
11.10.2 Research
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA
12.6.2 RNA
12.6.3 DNA/RNA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnosis
12.10.2 Research
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA
13.6.2 RNA
13.6.3 DNA/RNA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnosis
13.10.2 Research
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chlamydia Trachomatis Nucleic Acid Detection Kit Market: Competitive Dashboard
14.2 Global Chlamydia Trachomatis Nucleic Acid Detection Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sansure
14.3.2 Mole
14.3.3 Amplly
14.3.4 SinoMD
14.3.5 Kingmed
14.3.6 Daan
14.3.7 KHB
14.3.8 Innovita
14.3.9 Geneodx
